CagriSema - The other winning combo!
❇️ CagriSema The combination of cagrilintide and semaglutide in the treatment of obesity and type 2 diabetes. The two proteins appear to work synergistically to provide more robust and more permanent weight loss effects. https://diabetes.org/newsroom/press-releases/cagrisema-demonstrates-significant-weight-loss-adults-obesity ✅ This blend provides the benefit of rapid weight loss from semaglutide and the appetite suppression from cagrilintide. This is a viable option for those who have not been able to tolerate the stronger GLPs (Tirz/Reta) 🙌🏼 Not only that, but it is a very affordable option since these two peptides separately are very cost effective in comparison to other ones in the peptide space. 🔸 Semaglutide Semaglutide is a medicine used to treat type 2 diabetes and help with weight loss. It works by copying a natural hormone in the body called GLP-1. - Lowers blood sugar: Helps the body release insulin when sugar is high and reduces sugar made by the liver. - Supports weight loss: Reduces appetite and helps people eat less. - Slows digestion: Food moves more slowly through the stomach, helping control blood sugar and making you feel full longer. Semaglutide is given as an injection and is prescribed for people with type 2 diabetes or obesity. 1. Class and Target - Class: GLP-1 receptor agonist - Target: GLP-1 receptors in the pancreas, brain, and gut - What it is: A man-made version of GLP-1, a hormone that controls blood sugar and appetite 2. How It Controls Blood Sugar - Boosts insulin: Helps the pancreas release insulin only when blood sugar is high - Lowers glucagon: Reduces the hormone that raises blood sugar - Slows stomach emptying: Food digests more slowly, preventing blood sugar spikes after meals 3. How It Helps Weight Loss - Reduces appetite: Makes you feel full faster - Eats less: Lowers overall food intake - Reduces fat storage: Better blood sugar control can help reduce fat